1 active not recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Active not recruiting 1 |
Follow BRAF Gene Mutation: new trials by email Literature Review of BRAF Gene Mutation trials Research Report on BRAF Gene Mutation
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Cemiplimab Combined With Dabrafenib and Trametinib in People With Anaplastic Thyroid Cancer Dabrafenib, Trametinib - Anaplastic Thyroid Cancer, Thyroid Cancer | Phase 2 | Active not recruiting | Memorial Sloan Kettering Cancer Center | 16 | 2020-01-20 | 2026-07-06 |
Thyroid Carcinoma, Anaplastic (1) · Thyroid Neoplasms (1)
Carcinoma (1) · Endocrine Gland Neoplasms (1) · Endocrine System Diseases (1) · Head and Neck Neoplasms (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms by Site (1) · Neoplasms, Glandular and Epithelial (1) · Thyroid Diseases (1)
dabrafenib (1) · trametinib (1)
Memorial Sloan Kettering Cancer Center (1)
United States (1)
Eric Sherman, MD (1)